The Food and Drug Administration recently announced that it will launch a new research study to examine the link between cosmetic products, baby powder, and other products containing talcum powder and an increased risk of ovarian cancer. The FDA said that the new study, funded by the agency’s Office of Women’s Health, was being conducted because the links between talc and ovarian cancer “have not been adequately investigated.”
Talcum powder is made from talc – a naturally occurring mineral that is used in cosmetic products, baby powder, and many other commercial products. Several studies have suggested that women who use talcum powder for feminine hygiene in the genital area may face an increased risk of ovarian cancer or other diseases.
Despite this research, the link between talc and cancer affecting women remains controversial. Johnson & Johnson – the manufacturer of Johnson’s Baby Powder, Shower to Shower, and other talcum powder products used for feminine hygiene – has repeatedly denied a link between talcum powder and cancer even as the company has faced hundreds of lawsuits filed by women who were diagnosed with ovarian cancer or other diseases.
The FDA talcum powder study will attempt to determine how talcum powder might increase the risk of female cancers by examining the effect of talc on a molecular level. Although researchers believe that talc may cause irritation if it becomes lodged near the ovaries, the specific mechanism by which talc can cause ovarian cancer is still poorly understood by scientists.
In addition to the new study, the FDA’s Office of Color and Cosmetics has announced that it would launch a review of previous studies focusing on the link between talcum powder and ovarian cancer. Previous talcum powder studies have shown that women who use baby powder in the genital area may face an increased cancer risk. A 2013 study found that talcum powder users were 20-30% more likely to develop ovarian cancer. Other studies have found that African-American women who use talc products may face an even higher cancer risk.
Johnson & Johnson has been ordered to pay millions of dollars in damages to women who were diagnosed with cancer after using the company’s products. In February 2016, a jury in Missouri ordered Johnson & Johnson to pay $72 million to the family of an Alabama women who died from ovarian cancer after using Johnson’s Baby Powder, Shower to Shower, and other Johnson & Johnson talcum powder products. Subsequent trials have resulted in verdicts of $55 million and $70 million in favor of women who developed cancer as a result of using talc products sold by J&J. The company still faces hundreds of lawsuits over its talcum powder brands.
If you or a loved one used talcum powder products sold by Johnson & Johnson or another company for feminine hygiene and have been diagnosed with ovarian cancer, you may be eligible to file a lawsuit against the manufacturer or the talc supply company. The first step in finding out if you qualify is to speak with an experienced attorney who can advise you regarding your legal rights and options.
The lawyers at Heygood, Orr & Pearson represent dozens of women who were diagnosed with ovarian cancer as a result of exposure to talcum powder products. In addition to these cases, our firm has filed numerous product liability claims on behalf of our clients, including lawsuits involving dangerous drugs, defective medical devices, and other harmful commercial products.
Heygood, Orr & Pearson has filed cases against some of the largest corporations in the world on behalf of our clients. Our lawyers are dedicated to the belief that all consumers should have the right to qualified, experienced legal counsel to ensure that their rights are fully protected in a court of law.
For more information about the talcum powder lawsuits filed against Johnson & Johnson and to find out whether you may qualify to file a claim, contact the lawyers at Heygood, Orr & Pearson for a free legal consultation. You can reach us by calling toll-free at 1-877-446-9001, or by following the link to our free case evaluation form and answering a few short questions about your case to get started.